Cure My Disease

Don't miss your cure!

 Log in / Sign up

Drug combo safety checked in healthy volunteers

NCT ID NCT06665425

Completed Knowledge-focused Sponsor: JW Pharmaceutical Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed Phase 1 trial tested how two drugs, epaminurad and C2406, interact when taken together in 18 healthy adults aged 19 to 50. Researchers measured drug levels in the blood and checked for side effects. The goal was to see if combining them is safe and how the body processes each drug.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
epaminurad and C2406
What this could lead to
If successful, this could help doctors understand how to safely combine these two drugs in future treatments for conditions like gout.
What could go wrong
This is an early, small study in healthy people, not patients. It only checks safety and drug levels, not whether the drugs work for any disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY VOLUNTEERS

Contacts and locations

Locations

  • Seoul National University Hospital Clinical Trials Center

    Seoul, Seoul, 110-744, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.